Mental health comorbidity in cardiovascular heart disease: Implications for interdisciplinary intervention

Psychological Factors and Cardiovascular Disorders: The Role of Psychiatric Pathology and Maladaptive Personality Features

Volumn , Issue , 2008, Pages 311-338

  Ai, Amy L ^a   Appel, Hoa ^b   Pasic, Jagoda ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650184007     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (210)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al: Heart Disease and Stroke Statistics 2007. A Report from American Heart Association Statistics Committee and Stroke Subcommittee. Retrieved September 28, 2007 from http://circ.ahajournals.org/cgi/content/full/115/5/e69
2. Davidson KW, Kupfer DJ, Kaplan RM: Health psychology and scientific consensus: The case of depression and cardiovascular disease. Health Psychology 2007; 26: 519-520.
3. Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC et al: Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Annals Behavioral Med 2006; 32(2):121-126.
4. Ferketich AK, Binkley PF: Psychological distress and cardiovascular disease: results from the 2002 National Health Interview Survey. Eur Heart J 2005; 26(18):1923-1929.
5. Carroll D, Phillips AC, Hunt K, Der G: Symptoms of depression and cardiovascular reactions to acute psychological stress: Evidence from a population study. Biol Psychology 2007; 75: 68-74.
6. Ai, A L: Psychosocial adjustment and health care practices following coronary artery bypass surgery (CABG). Dissertation Abstracts International: Section B: The Sciences and Engineering 1996; 57(6-B): 4078.
7. Ai, A L: Qigong, in Micozzi, MS (Ed.), Fundamentals of complementary & integrative medicine, 3rd edition, pp. 418-436, 1996. St Louis, MO: Elsevier Health Sciences.
8. Ottawa Charter for Health Promotion. First International Conference on Health Promotion 1986. Retrieved November 12, 2007 from http://www.who.int/hpr/NPH/docs/ottawa_charter_hp.pdf
9. Mental illness as used in the National Comorbidity Survey-Replication (NCS-R) includes anxiety, mood, impulse-control, and substance abuse disorders as defined by the Diagnostic and Statistical Manual for Psychiatric Disorders-IV (DSM-IV), 4th ed., American Psychiatric Association, 2000.
10. Kessler, R.C., et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey-Replication (NCS-R). Arch Gen Psychiatry 2005; 62(6):617-627.
11. Keyes CL: Promoting and protecting mental health as flourishing: a complementary strategy for improving national mental health. American Psychologist 2007; 62(2):95-108.
12. Hogan, M.F. The President's New Freedom Commission: Recommendations to transform mental health care in America. Psychiatric Serv 2003; 54(11):1467-1474.
13. Office of the U.S. Surgeon General. Mental Health: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services (HHS), Public Health Service, 1999.
14. Hemingway H, Marmot MG. Psychosocial factors in the etiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999; 318: 1460-1467
15. Pignay-Demaria V, Lespérance F, Demaria RG, et al: Depression and anxiety and outcomes of coronary artery bypass surgery. Annals Thoracic Surg 2003; 75, 314-321.
16. Lett HS, Blumenthal JA, Babyak MA: Depression as a risk factor for coronary artery disease: evidence, mechanism, and treatment. Psychosom Med 2004; 66(3):305-315.
17. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99(16), 2192-2217.
18. Rumsfeld RS, Ho PM: Depression and cardiovascular disease: A call for recognition. Circulation 2005; 111(3):250-253.
19. Barth J, Schumacher M, Herrman-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosomat Med 2004; 66(6):802-813.
20. Van Melle JP, De Jonge P, Spijkerman TA, Tijssen JG, Ormel J, Van Veldhuisen DJ: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosomat Med 2004; 814-822.
21. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB: Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychia 2007; 64(2):242-249.
22. Rothenbacher D, Hahmann H, Wusten B, Koenig W, Brenner H: Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links. Eur J Cardiovasc Prev Rehabil 2007; 14(4):547-554.
23. Duits AA, Boeke S, Taamms MA.et al: Prediction of quality of life after coronary artery bypass graft surgery: A review and evaluation of multiple, recent studies. Psychosomat Med 1997; 59: 257-268.
24. Bhatia SC, Bhatia SK: Depression in Women: Diagnostic and treatment considerations. American Fam Phys 1999; 60(1): 225-240
25. Elliott RL: Depression in primary care. Ethn Dis 2007; 17(2supp): S2-28-33).
26. Feinstein RE, Blumenfield M, Orlowski B, Frishman WH, Ovanessian S: A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease. Cardiol Rev 2006; 14(4):164-169.
27. Murray CJ, Lopez AD: The global burden of disease: summary. Cambridge: Harvard School of Public Health, 1996.
28. Mosovich SA, Boone RT, Reichenberg A et al.: New insights into the link between cardiovascular disease and depression. Int J Clin Pract 2007; online article November 20, 2007, 1-10.
29. Alexopoulos GS, Meyers BS, Young RC, et al.: 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54: 915-922.
30. Thomas AJ, Kalaria RN, O'Brien JT: Depression and vascular disease: what is the relationship. J Affect Disord 2004; 79: 81-95.
31. Almeida OP, Flicker L, Norman P, et al.: Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatri Psychiatry 2007; 15: 506-513.
32. Lesperance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosomatic Medicine 1996; 58(2): 99-110.
33. Regier DA, Narrow WE, Rae DS, et al.: The de facto mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry 1993; 50(2): 85-94.
34. Aben I, Verhey F, Strik J, et al.: A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psych 2003; 74(5):581-585.
35. Burvill PW, Johnson GA, Jamrozik K, et al: The prevalence of depression following stroke: the Perth community stroke study. Br J Psychiatry 1995; 166: 320-327.
36. McConnell S, Jacka FN, Williams LJ, Dodd S, Berk M: The relationship between depression and cardiovascular disease. Int J Psychiat Clin Prac 2005; 9(3):157-167.
37. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Kirkwood FA, et al: Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007; 167: 367-373.
38. Westlake C, Dracup K, Fonarow G, Hamilton M. Depression in patients with heart failure. J Card Fail 2005; 11: 30-35.
39. Wulsin LR, Vaillant GE, Wells VE: A systematic review of the mortality of depression. Psychosomat Med 1999; 61: 6-17.
40. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005.
41. Wells KB, Burnam MA, Rogers W, et al.: The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch Gen Psych 1992; 49: 788-794.
42. Van der Kooy KG, van Hout HP, van Marjijk HWJ, de Haan M et al: Differences in heart rate variability between depressed and non-depressed elderly. Int J Geriatr Psychiatry 2006; 21: 147-150.
43. Ai, AL, Carrigan, LT: Social-Strata-Related cardiovascular health disparity and comorbidity in an aging society: Implications for professional care. Health and Soc Work 2007; 32(2):97-105.
44. Sheps DS, Sheffield D: Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. J Clin Psychiatry 2001: 62(Supp8):12-16.
45. Mykletun A, Bjerkeset O, Dewey M, Prince M et al: Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 2007; 69(4):323-331.
46. Frasure-Smith N, Lesperance F, Juneau M et al: Gender, depression, and one-year prognosis after myocardial infarction. Psychosomat Med 1999; 61: 26-37.
47. Kornstein SG: Gender differences in depression: implications for treatment. J Clin Psychiatry 1997; 58(supp15):12-18.
48. Grace SL, Abbey SE, Shnek ZM, Irvine J et al: Cardiac rehabilitation: review of psychosocial factors. Gen Hosp Psychiatry 2002; 24(3): 121-126
49. Maier W, Gansicke M, Gater R, Rezaki M, Tiemens B et al: Gender differences in the prevalence of depression: a survey in primary care. J Affect Disorders 1999; 53: 241-252.
50. Pinninelli M, Wilkinson G: Gender differences in depression: critical review. British J Psychiatry 2002; 177: 486-492.
51. Weissman MM, bland R, Joyce PR, Newman S, Wells JE, Wittchen HU: Sex differences in rates of depression: cross-national perspectives. J Affect Disorders 1997; 29: 77-84.
52. Wenger NK: You've come a long way, baby: Cardiovascular health and disease in women: Problems and prospects. Circulation 2004; 109(5):558-560.
53. Reis SE, Holubkov R, Smith JC et al: Coronary microvascular dysfunction is highly prevalent in women with chest pain the absence of coronary artery disease: Results from the NHLBI WISE study. Am Heart J 2001; 141: 735-741.
54. Andrew MJ, Baker RA., Kneebone AC, et al.: Mood state as a predictor of neuropsychological deficits following cardiac surgery. J Psychosomat Res 2000; 48: 537-546.
55. Boudrez H., De Backer, G: Psychological status and the role of coping style after coronary artery bypass graft surgery. Results of a prospective study. Qual Life Res 2001, 10, 37-47.
56. Mallik S, Krumholz HM, Lin ZQ, et al.: Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation 2005; 111: 271-277.
57. Ai, A.L, Peterson C, Bolling SF, Rodgers W: Depression, faith-based coping, and short-term post-operative global functioning in adult and older patients undergoing cardiac surgery. J Psychosomat Res 2006; 60: 21-28.
58. Ai, AL, Peterson C, Tice T N, et al.: Differential effects of faith-based coping on physical and mental fatigue in adult and older cardiac patients. Int J Psychiatr Med 2006; 36(3), 347-361.
59. Moser DK, Dracup K: Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events. Psychosom Med 1996; 58(5):395-401.
60. Fleet RP, Dupuis G, Martel JP, et al.: Two-year follow-up status of emergency department chest pain patients with panic disorder. Psychosom Med 1998; 60(1): 92.
61. Lynch P, Galbaraith KM: Panic in the emergency room. Can J Psychiatr 2003; 48(6):361-366.
62. Eaker ED, Sullivan, LM, Kelly-Hayes M, D'Agostino RB et al.: Tension and Anxiety and the Prediction of the 10-Year Incidence of Coronary Heart Disease, Atrial Fibrillation, and Total Mortality: The Framingham Offspring Study. Psychosom Med 2005; 67(5):692-696.
63. Paterniti S, Zureik M, Ducimetière P et al: Sustained Anxiety and 4-Year Progression of Carotid Atherosclerosis. Arterios Thrombo Vasc Biol 2001; 21: 136-141.
64. Vingerhoets G: Perioperative anxiety and depression in open-heart surgery. Psychosom Med 1998; 39: 30-7.
65. Williams RB: Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major disorders. J Psychiatr Res 1990; 24(supp 2):51-56.
66. Haines AP, Imeson JD: Phobic anxiety and ischemic heart disease. British Med J 1987; 295: 297-299.
67. Kawachi I, Colditz GA, Ascherio A, et al.: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997.
68. Kawachi I., Sparrow D, Vokonas PS, Weiss ST: Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90: 2225-2229.
69. Yan L, Liu K, Matthews KA et al.: Psychosocial Factors and Risk of Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA 2003; 290: 2138-2148.
70. Ortega AN, Feldman JM, Canino G, Steinman K, Alegria M: Co-occurrence of mental and physical illness in US Latinos. Soc Psychiatry and Psychatr Epidemiol 2006; 41(12):927-934.
71. Kubzansky LD, Kawachi I, Weiss ST, Sparrow D: Anxiety and coronary heart disease: A synthesis of epidemiological, psychological, and experimental evidence. Annals of Behavioral Medicine 1998; 20: 47-58.
72. Strike JJ H, Denollet J, Lousberg R, Honig A: Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. JAm Coll Cardiol 2003, 42(10):1801-1807.
73. Lynch J, Krause N, Kaplan GA et al.: Work place demands, economic reward, and progression of carotid atherosclerosis. Circulation 1997; 96: 302-307.
74. Theorell T, Tsutsumi A, Hallquist J et al.: Decision latitude, job strain and myocardial infarction: A study of working men in Stockholm. Am J Public Health 1998; 88(3):382-388.
75. Holmes TH, Rahe RH: The social readjustment rating scale. J Psychosom Res 1967; 11(2):213-218.
76. Pignalber C, Patti G, Chimenti C et al.: Role of different determinants of psychological distress in acute coronary syndromes. J Am Coll Cardiol 1998; 32: 613-619.
77. Leor J, Poole WK, Kloner RA: Sudden cardiac death triggered by an earthquake. New England J Med 1996; 334: 413-419.
78. Meisel SR, Kutz I, Dayan KI, et al.: Effects of Iraqui missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet 1991; 338: 660-661.
79. Vale SL: Psychological distress and cardiovascular disease. Postgrad Med J 2005; 81(957):429-435.
80. Fleet RP, Arsenault A, Lespérance F, et al.: Panic disorder in coronary artery disease patients ins associate with reversible myocardial perfusion defects during panic challenge with 35%CO2 [abstract]. Psychosom Med 2001, 63: 187.
81. Tennant C, McLean L: The impact of emotions on coronary heart disease risk. J Cardiovas Risk 2001, 8: 175-183.
82. Schelling G, Kilger E, Roozendaal B, et al.: Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: A randomized study. Biol Psychiatry 2004; 55: 627-633.
83. Stoll C, Schelling G, Goetz AE, et al.: Health-related quality of life and posttraumatic stress disorder in patients after cardiac surgery and intensive care treatment. J Thorac Cardiovas Surg 2000; 120: 505-512.
84. Ai AL, Peterson C, Tice TN, Huang BC et al.: The influence of prayer on mental health among cardiac surgery patients: The role of optimism and acute distress symptoms. J Health Psychol 2007; 12(4):580-596.
85. Williams RB: Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders. J Psychiatr Res 1990; suppl 2, 24: 51-56.
86. Burg M M., Jain D, Soufer R, et al.: Role of behavioral and psychological factors in mental stress-induced silent left ventricular dysfunction in coronary artery disease. J Am Coll Cardiology 1993; 22: 440-448.
87. Gidron Y, Davidson K, Bata I: The short-term effects of a hostility-reduction intervention in CHD patients. Health Psychology 1999; 18: 416-420.
88. Niaura R, Todaro J, Stroud L, Spiro A, et al.: Hostility, the metabolic syndrome, and incident coronary heart disease. Health Psychol 2002; 21(6):588-593.
89. J Julkunen, R Salonen, GA Kaplan, MA Chesney, and JT Salonen: Hostility and the progression of carotid atherosclerosis. Psychosom Med 1994; 56(6): 519-525.
90. Matsumoto Y, Uyama O, Shimizu S, Michishita H et al.: Do anger and aggression affect carotid atherosclerosis. Stroke 1993 ;24: 983-986.
91. Gallacher JEJ, Yarnell JWG, Sweetnam PM, Elwood PC et al.: Anger and Incident Heart Disease in the Caerphilly Study. Psychosom Med 1999; 61(4): 446-453.
92. Kawachi I, Sparrow D, Kubzansky LD, Spiro A et al.: Prospective study of a self-report type A scale and risk of coronary heart disease. Circulation 1998; 98: 405-412.
93. Krantz DS, Olson MB, Francis JL, Phankao C: Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: The Women's Ischemia Syndrome Evaluation (WISE) Study. Journal of Women's Health 2006, 15(10):1214-1223.
94. Miller TQ, Smith TW, Turner CW, Guijarro ML et al.: A meta-analytic review of research on hostility and physical health. Psychol Bull 1996; 119(2):322-348.
95. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB et al: Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring study. Circulation 2004; 109: 1267-1271.
96. Chang PP, Ford DE, Meoni LA, Wang NY et al.: Anger in young men and subsequent premature cardiovascular disease: The precursors study. Arch Intern Med 2002; 162: 901-906.
97. Williams JE, Paton CC, Siegler IC, Eigenbrodt ML et al.: Anger proneness predicts coronary heart disease risk: Prospective analysis from the atherosclerosis risk in community (ARIC) study. Circulation. 2000; 101: 2034-2039.
98. Knox SS, Adelman A, Ellison RC, Arnett DK et al.: Hostility, social support, and carotid artery atherosclerosis in The National Heart, Lung, and Blood Institute Family Heart Study. Am J Cardiol 2000; 86(10):1086-1089.
99. Chaput LA, Adams SH, Simon JA, Blumenthal RS et al.: Hostility predicts recurrent events among postmenopausal women with coronary heart disease. Am J Epidemiol 2002; 156(12):1092-1099.
100. Helmers KF, Krantz DS, Howell RH, Klein J et al.: Hostility and myocardial ischemia in coronary artery disease patients: evaluation by gender and ischemic index. Psychosom Med 1993; 55(1): 29-36.
101. Olson MB, Krantz DS, Kelsey SF, Pepine CJ et al.: Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: A report from the NHLBI-sponsored WISE study. Psychosom Med 2005; 67: 546-552.
102. Williams JE, Nieto FJ, Sanford CP, Couper DJ et al.: The association between trait anger and incident stroke risk: The atherosclerosis risk in communities (ARIC) study. Stroke 2002; 33: 13-20.
103. Suarez EC: Joint Effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 2003; 65: 523-527.
104. Schulman JK, Stromberg S: On the value of doing nothing: Anger and cardiovascular disease in clinical practice. Cardiol in Rev 2007; 15: 123-132.
105. Denollet J: Type D personality: A potential risk factor refined. J Psychosom Res 2000; 49: 255-266.
106. Denollet J, Brutsaert DL: Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998; 97: 167-173.
107. Denollet J, Vaes J, Brutsaert DL: Inadequate response to treatment in coronary heart disease: Adverse effects of type D personality and younger age on a 5-year prognosis and quality of life. Circulation 2000; 102: 630-635.
108. Sher L: Type D personality: the heart, stress, and cortisol. QJM 2005; 98: 323-329.
109. Jarett DB, Lloyd-Jones DM, Garside DB, Wang R et al.: Social avoidance and long-term risk for cardiovascular disease death in healthy men: The Western Electric Study. Ann Epidemiol 2007; 17(8):591-596.
110. Anda R, Williamson D, Jones D, Macera C et al: Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiol 1993; 4: 285-294.
111. Everson SA, Goldberg DE, Kaplan, GA Cohen RD et al.:. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996; 58: 113-121.
112. Schwarz AM, Schächinger H, Adler RH, Goetz SM: Hopelessness as Associated with decreased heart rate variability during championship chess games. Psychosom Med 2003; 65: 658-661.
113. Stern SL, Dhanda R, Hazuda HP: Hopelessness predicts mortality in older Mexican and European Americans. Psychosom Med 2001; 63: 344-351.
114. Everson SA, Kaplan GA, Goldberg GE, Salonen R et al.: Hopelessness and 4-year progression of carotid atherosclerosis: The Kuopio ischemic heart disease risk factor study. Arterioscler Thromb Vasc Biol 1997; 17: 1490-1495.
115. Carney RM, Freedland KE, Miller J et al: Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res 2002, 53, 897-902.
116. Fraguas R, Iosifescu DV, Bankier B, Perlis R et al.: Major depressive disorder with anger attacks and cardiovascular risk factors. Int J Psychiatr Med 2007; 37(1):99-111.
117. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-2107.
118. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psych 1998; 55: 580-592.
119. Singh RB, Kartik C, Otsuka K, Pella D, Pella J: Brain-heart connection and the risk of heart attack. Biomed Pharmacother 2002; 56(2suppl): 257s-265s.
120. Van der Kooy K, van Hout H, Marjijk H, Marten H et al: Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatric Psychia 2007; 22(7):613-626.
121. Musselman DL, Tomer A, Manatunga AK, Kinght BT et al.: Exaggerated platelet reactivity in major depression. Am J Psychiatr 1996; 153: 1313-1317.
122. Laghrissi-Thode F, Wagner WE, Pollock BG, Johnson PC et al.: Elevated platelet factor 4 and beta-thromoglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatr 1997; 42: 290-295
123. Study of the effectiveness of additional reductions in cholesterol and homocysteine(SEARCH): Characteristics of a randomized trial among 12,064 myocardial infarction survivors. Am Heart J 2007, 154(5):815-823.
124. Mischoulon D, Raab MR: The role of folate in depression and dementia. J Clin Psychiatr 2007; 68(suppl 10):28-33.
125. Roberts SH, Bedson E, Hughes DA, Lloyd KR, et al: Folate Augmentation of treatment- evaluation for depression (FolATED): Protocol of a randomized controlled trial. BMC Psychiatr 2007; 7: 65.
126. Williams A, Girard C, Jui D, Sabina Am et al.: S-Adenolosylmethionine (SAMe) as treatment for depression: A systematic review. Clin Invest Med 2005; 28(3):132-139.
127. Carney R: Omega-3 acids to improve depression and reduce cardiovascular risk factors. Accessed November 27, 2007 htt://clinicaltrials.gov/ct2/show/NCT00116857.
128. Anisman H, Merali Z: Cytokines, stress, and depressive illness. Brain Behav Immun 2006; 16: 513-524.
129. Black PH, Garbutt LD: Stress, inflammation and cardiovascular disease. J Psychosom Res 2002; 52: 1-23.
130. Miller GE, Blackwell E: Turning up the heat: Inflammation as a mechanism linking chronic stress, depression and heart disease. Curr Dir Psychol Sci 2006, 15(6):269-272.
131. Mosovich SA. Boone RT, Reichenber A, Bansilal S, et al: New insights into the link between cardiovascular disease and depression. Int J Clin Prac 2007; doi 10.1111: 1-10.
132. Appels A, Bar FW, Bar J, Bruggeman C, De Baets M: Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000; 62: 601-605.
133. Pasic J, Levy WC, Sullivan MD: Cytokines in depression and heart failure. Psychosom Med 2003; 65: 181-193.
134. Dantzer R, Wollman E, Vitkovic L, Yirmiya R: Cytokines and depression: fortuitous or causative association. Molec Psychiatr 1999; 4(4): 328-332.
135. Libby P, Ridker PM: Novel inflammatory markers of coronary risk: Theory versus practice. Circulation 1999; 100(11):1148-1150.
136. Libby P, Theroux P: Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481-3488.
137. Rauch B, Schiele R, Schneider S, Gohlke H et al: Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA study. Cardiovasc Drugs Ther 2006; 20: 365-375.
138. Capuron L, Miller AH: Cytokines and psychopathology: Lessons from interferon-a. Biol Psychiatr 2004, 56(11):819-824.
139. Danner M, Kasl SV, Abramson JL, Vaccarino V: Association between depression and elevated C-reactive protein. Psychosom Med 2003; 65: 347-356.
140. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, et al.: Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89: 419-424.
141. Penninx BWJ, Kritchevsky SB, Yaffe K, Newman AB: Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biological Psychiatr 2003, 54(5):566-572.
142. Zoririlla EP, Luborsky L, McKay JR, Rosenthal R: The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behav Immun 2001; 15: 199-226.
143. Empana JP, Sykes DH, Luc G, Juhan-Vague I, et al.: Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005; 111: 2299-2305.
144. Miller GE, Stetler CA, Carney RM, Freedland KE, et al.: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1983.
145. Shimbo D, Chaplin W, Crossman D, Hass D, et al.: Role of Depression and Inflammation in Incident Coronary Heart Disease Events. Am J Cardiol 2005; 96(7):1016-1021.
146. Vaccarino V, Johnson BD, Sheps DS, Reis SE, et al.: Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: The National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 2007; 50(21):2044-2050.
147. Watkins LL, Grossman P, Krishman R, Sherwood A: Anxiety and vagal control of heart rate. Psychosom Med 1998; 60: 498-502.
148. Bjork JM, Dougherty DM, Moeller FG: Symtomatology of depression and anxiety in female 'social drinker'. Am J Drug Alc Abuse 1999; 25(1): 173-182.
149. Black DW, Zimmerman M, Coryell WH: Cigarette smoking and psychiatric disorder in a community sample. Ann Clin Psychiatr 1999; 11(3): 129-136.
150. Stoney CM: Plasma homocysteine levels increase in women during psychological stress. Life Sci 1999; 64(25):2359-2365.
151. Ueland PM, Refsum H: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473-501.
152. Heinz A, Hermann D, Smolka MN, Rieks M, et al.: Effects of acute psychological stress on adhesion molecules, interleukins and sex hormones: implications for coronary heart disease. Psychopharm 2003; 165(2):111-117.
153. Owen N, Poulton T, Hay FC, Mohamed-Ali V, et al.: Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003; 17: 286-295.
154. Bierhaus A, Wolf J, Andrassy M, Rohleder N, et al.: A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci US Am 2003; 100: 1920-1925.
155. Murray DR, Prabhu SD, Chandrasekar B: Chronic ß-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine Expression. Circulation. 2000; 101: 2338-2341.
156. Matthews KA, Owens JF, Kuller LH, Sutton-Tyrrell K, et al.: Are Hostility and Anxiety Associated With Carotid Atherosclerosis in Healthy Postmenopausal Women. Psychosom Med 1998; 60: 633-638.
157. Räikkönen K, Matthews KA, Sutton-Tyrrell K, Kuller LH: Trait anger and the metabolic syndrome predict progression of carotid atherosclerosis in healthy middle-aged women. Psychosom Med 2004; 66: 903-908.
158. Anderson DE, Metter EJ, Hougaku H., Najjar SS: Suppressed anger is associated with increased carotid arterial stiffness in older adults. Am J Hyperten 2006; 19(11):1129-1134.
159. Suarez EC: Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 2003; 65: 523-527.
160. Krantz DS, McCeney MK: Effects of psychological and social factors on organic disease: A critical assessment of research on coronary heart disease. Ann Rev Psychol 2002; 53: 341-369.
161. Rutledge T, Reis SE, Olson M, Owens J, et al.: Psychosocial variables are associated with atherosclerosis risk factors among women with chest Pain: The WISE study. Psychosom Med 2001; 63: 282-288.
162. Fraguas R, Papakostas GI, Mischoulon D, Bottiglieri T, et al.: Anger attacks in major depressive disorder and serum levels of homocysteine. Biol Psychiatr 2006; 60(3):270-274.
163. Peterson C: The future of optimism. Am Psychol 2000; 55: 44-55.
164. Ai AL, Peterson C, Bolling SF, Koenig H: Private prayer and the optimism of middle-age and older patients awaiting cardiac surgery. The Gerontologist 2002; 42: 70-81.
165. Carver CS, Spencer SM, Scheier MF: Optimism, motivation, and mental health. In N.S. Friedman (Ed), Encyclopedia of mental health (Vol.3, pp.41-52). San Diego, CA: Academic Press.
166. Shen B-J, McCreary CP, Myers HF: Independent and mediated contributions of personality, coping, social support, and depressive symptoms to physical functioning outcome among patients in cardiac rehabilitation. J Behav Med 2004; 27(1):39-62.
167. Bedi G, Brown SL: optimism, coping style and emotional well-being in cardiac patients. Brit J Health Psychol 2005; 10: 57-70.
168. Giltany EJ, Geleijnse JM, Zitman FG et al: Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly Dutch men and women. Arch Gen Psychiatry 2004; 61: 1126-1135.
169. Helgeson VS, Fritz HL: Cognitive adaptation as a predictor of new coronary events after percutaneous tranluminal coronary angioplasty. Psychosom Med 1999; 61: 488-495.
170. Pirraglia PA, Peterson JC, Williams-Russo P et al: Depressive symptomatology in coronary artery bypass graft surgery patients. Ann Thoracic Surg 1999; 14: 668-680.
171. Sykes DH, Hanley M, Boyle DM et al: Work strain and the post-discharge adjustment of patients following a heart attack. Psychol Health 2000; 15: 609-623.
172. van Elderen T, Maes S, Dusseldorp E: Coping with coronary heart disease: A longitudinal study. J Psychosom Res 1999; 47: 175-183.
173. Ai AL, Park C, Huang B, Rodgers W, Tice TN: Psychosocial mediation of religious coping: A prospective study of short-term psychological distress after cardiac surgery. Personal and Soc Psychology Bulletin 2007; 33(6):867-882.
174. Lewis SC, Dennis MS, O'Rourke S J, Sharpe, M: Negative attitudes among short-term stroke survivors predict worse long-term survival. Stroke 2001; 32: 1640-1645.
175. Sarker U, Sadia A, Whooley MA: Self-efficacy and health status in patients with coronary heart disease: Findings from the heart and soul study. Psychosom Med 2007; 69: 306-312.
176. Oxman TE, Hull JG: Social support, depression, and activities of daily living in older heart surgery patients. J Geron Psychol Sci 1997; 52b:1-14.
177. Krause N, Ellis Oxman TE, Hull JG: Social support, depression, and activities of daily living in older heart surgery patients. J Geron Psychol Sci 1997; 52B:1-14.
178. Krause N: Church-based social support and health in old age: Exploring variations by race. J Gerontol 2002; 57B: S332-S347.
179. Powell LH., Shahabi L, Thoresen, CE: Religion and spirituality: Linkages to physical health. Am Psychol 2003, 58, 36-52.
180. Hughes JW, Sketeh MH, Watkins LL: Social support and religiosity as coping strategies for anxiety in hospitalized cardiac patients. Ann Behav Med 2004; 24: 179-185.
181. Oxman TE, Freeman DH, Manheimer ED: Lack of social participation or religious strength and comfort as risk factors for death after cardiac surgery in the elderly. Psychosom Med 1995; 57: 5-15.
182. Contrada RJ, Goyal TM, Cather C, Rafalson L et al.: Psychosocial factors in outcomes of heart surgery: the impact of religious involvement and depressive symptoms. Health Psychol 2004; 23: 227-238.
183. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E: Preferences for treatment outcomes in patients with heart failure: Symptoms versus survival. J Cardiol Fail 2000; 6(3):225-232.
184. Newman S: The psychological perspective: a professional view. Heart 2003; 89(Suppl2):ii16-18.
185. Screening for depression: recommendations and rationale. U.S. Preventive Services Task Force. Annals Int Med 2002; 136(10):760-764.
186. Adams K, Corrigan JM, eds: Priority areas for national action: Transforming health care quality. Washington, DC: The National Academic Press, 2003.
187. Chung H, Teresi J, Guarnacci P, Meyers BS, Holmes D et al: Depressive symptoms and psychiatric distress in low income Asian and Latino primary care patients: Prevalence and recognition. Comm Ment Health J 2003; 39(1):33-46.
188. Brown C, Abe-Kim JS, Barrio C: Depression in ethnically diverse women: Implications for treatment in primary care settings. Prof Psych: Res and Prac 2003; 34(1): 10-19.
189. Gilbody S, Whitty P, Grimshaw J, Thomas R: Educational and organizational interventions to improve the management of depression in primary care. JAMA 2003; 289(23):3145-3151.
190. Beck AT, Steer RA, Ball R, Ranieri WF: Comparison of Beck Depression Ineventories-IA and -II in Psychiatric Outpatients. J Personal Assess 1996; 67(3):588-597.
191. Ensel, W. Measuring depression: The CES-D Scale. Social Support, Life Events and Depression. N. Lin, A. Dean and W. M. Ensel. New York: Academic Press, 1986.
192. Hofer S, Lim L, Guyatt G, Oldridge N: The MacNew heart disease health-related quality of life instrument: A summary. Health and Quality of Life Outcomes 2004. Retrieved October 3, 2007 from http://www.hqlo.com/content/pdf/1477-7525-2-3.pdf
193. Hunt SA, Baker DW, Chin MH et al: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology, American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001; 38: 2101-2113.
194. Berkman LF, Blumenthal J, Burg M et al: Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106-3116.
195. Serebruany VL, Suckow RF, Cooper TB et al: Sertraline antidepressant Heart Attack Randomized Trial. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmehtylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatr 2005; 162: 1165-1170.
196. Shah SU, Iqbal Z, White A, White S: Heart and mind: psychotropic and cardiovascular therapeutics. Postgrad Med J 2005; 81(951):33-40.
197. Lesperance F, Frasure-Smith N, Koszycki D, Laliberte M-A: Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients with Coronary Artery Disease. JAMA 2007; 297: 367-379.
198. Fuchs E, Czeh B, Flugge G: Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. Behav Pharmacol 2004; 15: 315-325.
199. Glassman AH, O'Connor CM, Califf RM et al: Sertraline treatment of major depression inpatients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
200. Tuglu C, Kara SH, Caliyurt P, Vardar E, Abay E: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharm 2003; 170: 429-433.
201. Swenson JR, O'Connor CM, Barton D, Van Zyl LT, et al.: Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003; 92: 1271-1276.
202. ENRICHD Investigators: Effects of treating depression and low perceived social support on clinical events after -myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289(23), 3106-16.
203. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, et al.: Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The sertraline antidepressant heart attack randomized trial (SADHART) platelet substudy. Circulation 2003; 108: 939-944.
204. Schatzberg AF, Rush AJ, Arnow BA et al: Chronic depression: Medication or psychotherapy is effective when the other is not. Arch Gen Psychiatry 2005; 62: 513-520.
205. ENRICHD Investigators: Enhancing recovery in coronary heart disease (ENRICHD) study intervention: Rationale and design. Psychosom Med 2001; 63(5):747-755.
206. Van Voorhees BW, Walters AE, Prochaska M, Quinn MT: Reducing health disparities in depressive disorders process of care and outcomes between whites and ethnic minorities: Call for a comprehensive and pragmatic approach. Med Care Res Rev 2007; 64(Suppl): 157S-194S.
207. American Heart Association 2002. Heart and stroke statistical update. Dallas, TX: American heart Association.
208. Irvine J, Ritvo P: Health risk behavior change and adaptation in cardiac patients. Clin Psychol Psychother 1998; 5: 86-101.
209. Katon W, Von Korkoff M, Lin E, Simon G, Walker E, et al: Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial. Arch Gen Psychiatr 1999; 56: 1109-1115.
210. Lobo CM, Frijling BD, Hulscher ME, Bernsen RM, et al.: Effect of a comprehensive intervention program targeting general practice staff on quality of life in patients at high cardiovascular risk: a randomized controlled trial. Qual Life Res 2004; 13: 73-80.